Lawrence Shulman, MD
Chief Medical Officer and Senior VP for Medical Affairs, Dana-Farber Cancer Institute and Associate Professor of Medicine, Harvard Medical School

Lawrence N. Shulman, M.D., is Chief Medical Officer, Senior Vice-President for Medical Affairs, and Chief, Division of General Oncology, Department of Medical Oncology at Dana-Farber Cancer Institute. He focuses his efforts on the clinical services for both adult and pediatric care at the Dana-Farber Cancer Institute (DFCI) and its partners, Brigham and Women's Hospital, and Children's Hospital.

Dr. Shulman has served as one of the component leaders through the DFCI strategic planning initiative. He is Director of Network Development for Dana-Farber/Brigham and Women's Cancer Center, and oversees DFCI ambulatory oncology units at several regional sites. He is also physician leader for the development of clinical information systems for DFCI. He is Chair of the American Society of Clinical Oncology's (ASCO) Quality of Care Committee and a member of ASCO's Electronic Health Record Workgroup. He is also a member of the ASCO Workgroup on Provider/Payer Initiatives.  He is a member of the Commission on Cancer of the American College of Surgeons, and Vice-Chair of their Quality Integration Committee. A specialist in the treatment of patients with breast cancer, his research includes development of new cancer therapies.

He works closely with Partners in Health, where he is Senior Advisor in Oncology, helping to lead the development of a structured cancer program for their resource-limited healthcare sites in Rwanda, Malawi and Haiti.   He is co-chair, together with Dr. Julio Frenk, Dean of the Harvard School of Public Health, of the Global Task Force on Expanding Access to Cancer Care and Control in the Developing World, a Harvard-based, international task force committed to the improvement of cancer care worldwide.

Source:  Information provided by Dana-Faber Cancer Institute on behalf of Lawrence Shulman.